home / stock / mnkpf / mnkpf short
Short Information | Mallinckrodt (OTCMKTS:MNKPF)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 107,720 |
Total Actual Volume | 982,611 |
Short Trends | |
---|---|
Cover Days | 16 |
Short Days | 1 |
No Change Days | 3 |
Averages | |
---|---|
Average Short Volume | 5,386 |
Average Short Percentage | 14.99% |
Is there a MNKPF Short Squeeze or Breakout about to happen?
See the MNKPF Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
09-22-2022 | $0 | $17.94 | $0 | $0 | 9 | 4 | 44.44% |
09-15-2022 | $15.5 | $17.95 | $18 | $15.5 | 28,683 | 700 | 2.44% |
08-16-2022 | $11.3 | $11.4 | $11.4 | $11.3 | 49,076 | 6,500 | 13.24% |
08-15-2022 | $11.35 | $11.35 | $11.45 | $11.25 | 50,504 | 1,808 | 3.58% |
08-04-2022 | $16.4 | $17 | $17 | $16 | 27,332 | 3,500 | 12.81% |
08-03-2022 | $16.5 | $16.65 | $16.79 | $16 | 35,142 | 1,500 | 4.27% |
07-29-2022 | $17.99 | $17.5 | $17.99 | $16.5 | 83,415 | 28,579 | 34.26% |
07-28-2022 | $15.55 | $16 | $16.05 | $15.5 | 49,569 | 6,000 | 12.1% |
07-26-2022 | $15.5 | $15.5 | $15.5 | $15.5 | 809 | 1 | 0.12% |
07-19-2022 | $19 | $19 | $19 | $19 | 1,104 | 100 | 9.06% |
07-18-2022 | $20.1 | $19 | $20.1 | $19 | 22,473 | 101 | 0.45% |
07-15-2022 | $20.5 | $20.5 | $20.5 | $20.25 | 54,796 | 25,600 | 46.72% |
07-13-2022 | $21 | $20.75 | $21 | $20.5 | 34,717 | 12,534 | 36.1% |
07-07-2022 | $23.9 | $23.88 | $23.9 | $23.8 | 12,165 | 400 | 3.29% |
07-06-2022 | $24 | $23.95 | $24 | $23.8 | 64,029 | 2,200 | 3.44% |
06-29-2022 | $27 | $24.5 | $27 | $24.5 | 364,272 | 100 | 0.03% |
06-28-2022 | $29 | $26.75 | $29.1 | $25.5 | 19,443 | 2,723 | 14.01% |
06-27-2022 | $25.5 | $25.5 | $26 | $25.5 | 17,708 | 1,000 | 5.65% |
06-24-2022 | $26 | $25.25 | $26 | $25.25 | 26,639 | 14,270 | 53.57% |
06-23-2022 | $24 | $24.75 | $24.75 | $24 | 40,726 | 100 | 0.25% |
News, Short Squeeze, Breakout and More Instantly...
Mallinckrodt Company Name:
MNKPF Stock Symbol:
OTCMKTS Market:
Mallinckrodt plc Reports Fourth Quarter and Fiscal 2022 Financial Results and Provides 2023 Guidance PR Newswire Made Solid Progress on Launch of Terlivaz® with Significant Medical Community Interest Appointed Chief Scientific Officer with Proven Record of Executi...
Mallinckrodt to Present at Cowen's 43rd Annual Health Care Conference PR Newswire DUBLIN , Feb. 16, 2023 /PRNewswire/ -- Mallinckrodt plc (NYSE American: MNK), a global specialty pharmaceutical company, today announced that Siggi Olafsson , President ...
Mallinckrodt plc Reports Third Quarter 2022 Financial Results and Reaffirms Guidance PR Newswire Launched Terlivaz ® Following U.S. Food and Drug Administration (FDA) Approval in September; Submitted U.S. FDA Premarket Notification Application for Next-Generat...